Westpac Banking Corp’s PDL BioPharma, Inc. PDLI Stock Holding History

Westpac Banking Corp’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-582,608	Closed	-$4.49M	–	994
2014 Q4	$4.49M	Hold	582,608	–	–	0.04%	382
2014 Q3	$4.35M	Hold	582,608	–	–	0.04%	365
2014 Q2	$5.64M	Sell	582,608 -134,300	-19%	-$1.2M	0.05%	316
2014 Q1	$5.96M	Buy	716,908 +313,500	+78%	+$2.69M	0.06%	281
2013 Q4	$3.4M	Buy	403,408 +142,000	+54%	+$1.2M	0.04%	372
2013 Q3	$2.08M	Buy	261,408 +50,100	+24%	+$403K	0.03%	440
2013 Q2	$1.54M	Buy	+211,308	New	+$1.65M	0.02%	456

Other funds holding PDLI

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Westpac Banking Corp's PDLI Position: Q1 2015 in Review

Westpac Banking Corp sold out of PDL BioPharma, Inc. (PDLI) in Q1 2015, closing a stake of 582,608 shares — an estimated $4.49M sold.

Westpac Banking Corp first reported a position in PDLI in Q2 2013 and held it in 7 quarters. The position peaked at $5.96M in Q1 2014. 215 funds tracked by Wall St. Rank hold PDLI as of Q1 2015.

Westpac Banking Corp reported no remaining PDL BioPharma, Inc. position as of Q1 2015 after selling out during the quarter.
Westpac Banking Corp sold 582,608 PDL BioPharma, Inc. shares in Q1 2015, an estimated $4.49M.
Westpac Banking Corp first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 7 quarters.
Westpac Banking Corp's PDL BioPharma, Inc. position peaked at $5.96M in Q1 2014.
215 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2015.

Based on Westpac Banking Corp's 13F filing for Q1 2015, filed 12 May 2015.